Abstract
Meningiomas are principally benign in nature. Some meningiomas, however, grow fast or recur even after total removal. The biological behavior of meningiomas often can not be predicted from conventional histopathological studies. A monoclonal antibody against proliferating cell nuclear antigen (PCNA) was used to investigate the usefulness of the PCNA index as a parameter to estimate the proliferative activity of meningiomas. Fifty-two meningiomas were examined. The mean PCNA index of recurrent meningiomas (3.37±0.92%) was significantly higher than that of non-recurrent meningiomas (1.12±0.51%) (p <0.005). The PCNA indices of recurrent cases were all higher than 2.0%. A semilog linear regression analysis between tumor doubling time and PCNA index showed a significant correlation (r=0.90, p < 0.05). An inverse linear correlation between PCNA index and interval to recurrence was observed (r=0.62, p < 0.05). A good linear correlation was also shown between PCNA index and BUdR labeling index (r = 0.88, p < 0.01). The results of this study suggest that, providing the methods of tissue processing, immunostaining and counting of positive nuclei are unified, the PCNA index is a useful parameter for estimating the biological behavior of meningiomas.
Similar content being viewed by others
References
Bravo R, Frank R, Blundell PA, Bravo HM: Cyclin/PCNA in the auxiliary protein of DNA polymerase-delta. Nature 326: 515–517, 1987
Bravo R, Bravo HM: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle. Association with DNA replication sites. J Cell Biol 105: 1549–1554, 1987
Danova M, Riccardi A, Giordano M, Girino M, Mazzini G, Dezza L: Cell cycle-related protein. A flow cytometric study in human tumors. Biol Cell 64: 23–28, 1988
Waseem NH, Lane D: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). J Cell Sci 96:121–129, 1990
Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22–39, 1957
Grantzner HG: Monoclonal antibody to 5-bromo and 5-iodo-deoxyuridine. A new reagent for detection of DNA replication. Science 218: 474–475, 1982
Hoshino T, Nagashima T, Murcovic JA, Wilson CB, Edwards MSB, Gutin PH:In situ cell kinetics studies on human neuroectodermal tumors with bromo-deoxyuridine labeling. J Neurosurg 64: 453–459, 1986
Burger PC, Shibata T, Kleihaus P: The use of the monoclonal antibody Ki-67 in the identification of proliferating cells. Application to surgical neuropathology. Am J Surg Pathol 10: 611–617, 1986
Gades J, Bocher MHG, Key C, Cattoretti G: Immunohistological detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissue. J Pathol 168: 85, 1992
Key G, Bocher MHG, Ducrow M, Schluter C, Gerdes J: New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) prepared against recombinant parts of Ki-67 antigen. Anal Cell Pathol 4: 181, 1992
Robbins BA, Vega D, Ogata K, Tan EM, Nakamura RM: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Acta Pathol Lab Med 111: 841–845, 1987
Al-Sheneber I, Shibata HR, Sampalis J, Jothy S: Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71: 1954–1959, 1993
Beppu T, Arai H, Sasaki K: Measurement of PCNA labeling index in astrocytic tumors. No Shinkei Geka 20: 1255–1259, 1992 (in Japanese)
Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134: 733–739, 1989
Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections. An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 2285–2294, 1990
Tabuchi K, Honda C, Nakane DK: Demonstration of proliferating cell nuclear antigen (PCNA/cyclin) in glioma cells. Neurol Med Chir (Tokyo) 27: 1–5, 1987
Galand P, Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22: 383–392, 1989
Kawakita N, Seki S, Sakagichi H, Yanai A, Kuroki T, Mizoguchi Y, Kobayashi K, Monna T: ANalysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissue from various liver disease fixed in formaldehyde. Am J Pathol 140: 513–520, 1992
Landberg G, Roos G: Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell analysis. Cancer Res 51: 4570–4574, 1991
Schiffer D, Chio A, Giordana MT, Pezzulo T, Vigliani MC: Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: An immunohistochemical study. Acta Neuropathol 85: 495–502, 1993
Allengranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta M, Polio B, Dalla Palma P, Barbareschi M: Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Archiv A Pathol Anat 419: 417–423, 1991
Karamitopoulou E, Perentes E, Melachinou M, Maraziotis T: Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85: 316–322, 1993
Nakasu S, Nakajima M, Nioka H, Matsumura K, Handa J: Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index. Neurol Med Chir (Tokyo) 34: 269–273, 1994
Chan RC, Thompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningiomas: Retrospective study in 257 cases. J Neurosurg 60: 52–60, 1984
Giombini S, Solero CL, Morello G: Late outcome of operations for supratentorial convexity meningiomas: Report of 2–7 cases. Surg Neurol 22:588–594, 1984
Jaaskelainen J: Seemingly complete removal of histologically benign intracranial meningioma: Late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:165–172, 1985
Waga S, Yamashita J, Handa H: Recurrence of meningiomas. Neurol Med Chir (Tokyo) 17: 203–208, 1977 (in Japanese)
Yamashita J, Handa H, Iwaki K, Abe M: Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 14: 33–40, 1980
Adegbite AB, Khan MI, Paine KWE, Tan LK: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58: 51–56, 1983
Boker D-K, Meuer H, Gullota F: Recurring intracranial meningiomas: Evaluation of some factors predisposing for tumor recurrence. J Neurosurg Sci 29: 11–17, 1985
Jellinger K, Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 24: 279–298, 1975
Hoshino T, Nagashima T, Murcovic JA, Wilson CB, Davis RL: Proliferative potential of human meningiomas of the brain: A cell kinetics study with bromodeoxyuridine. Cancer 58: 1466–1472, 1986
May PL, Broome JC, Lawry J, Buxton RA, Battersby RDE: The prediction of recurrence in meningiomas: A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71: 347–351, 1989
Shibata T, Burger PC, Kleihues P: Cell kinetics of human meningiomas: Ki-67 PAP stain. No Shinkei Geka 16: 939–944, 1988 (in Japanese)
Orita T, Kajiwara K, Nishizaki T, Ikeda N, Kamiryo T, Aoki H: Nucleolar organizer regions in meningiomas. Neurosurgery 26: 43–46, 1990
Zimmer C, Gottschalk J, Cervos-Navarro J, Martin H, Beil M, Jautzke G: Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Path Res Pract 188: 951–958, 1992
Pearlman AW: Breast cancer — influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrence. Cancer 38: 1826–1833, 1976
Cho KG, Hoshino T, Nagashima T, Murovic J, Wilson CB: Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling. J Neurosurg 65: 790–794, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakabayashi, H., Sakaguchi, M., Katsuyama, J. et al. Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression. J Neuro-Oncol 24, 209–217 (1995). https://doi.org/10.1007/BF01052837
Issue Date:
DOI: https://doi.org/10.1007/BF01052837